>
The discovery that genome engineering could be accomplished by harnessing the bacterial CRISPR-Cas9 immune defense system is one of the most-important scientific breakthroughs of our time. Like a high-precision, programmable pair of molecular scissors, this incredible tool can be used to edit any genetic sequence—deleting, exchanging, and inserting. It has ushered in a new era in which genomic manipulation is no longer a bottleneck to discovery, transforming plant and animal biology, biotechnology, and human therapeutics.
Dr. Emmanuelle Charpentier: Founding Scientific and Managing Director, Max Planck Unit for the Science of Pathogens, Berlin; Honorary Professor, Humboldt University, Berlin; 2018 Kavli Prize Laureate in Nanoscience
#CRISPR
The conversation will be moderated by George Washington University School of Media and Public Affairs Director and Emmy winning journalist Frank Sesno.
Co-hosted by the Carnegie Institution for Science with The Kavli Foundation, the Royal Embassy of Norway, and the Norwegian Academy of Science and Letters. The Kavli Prize is a partnership between The Norwegian Academy of Science and Letters, The Kavli Foundation (United States), and The Norwegian Ministry of Education and Research.
